Wave Life Sciences, Inc. (WVE) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGM. Market cap 683.76M USD. 52-week range 3.37 to 21.73 USD. Data as of 2026-10-09.
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) ...